Category: Business

Uncap Logo
CHICAGO – November 1, 2022 – (Newswire.com)

After near…

AURORA, Ontario – November 1, 2022 – (Newswire.com)

Sinclair Technologies announces its first model of the new SSOP1 Series – a 14-port Small Cell Antenna with multi-band support, including low-band, mid-band, CBRS and LAA. 

This high-performance antenna was designed specifically for various types of applications, offering long life and reliability with a range of options suitable for any project. With its UV-resistant fiberglass radome and durable build, SSOP1 thrives in weather prone to harsh elements. Sinclair’s small cell antenna is ideal for MIMO applications, providing outstanding 360⁰ coverage and high-speed capacity. Its compact size allows for easy installation and fast deployment, while extensive customizations from port counts, frequency bands to tilts and radiation patterns, offer flexibility in coverage solutions.

Some of the features include: 

• Up to 14 ports quasi-omni small cell antenna, with future models accommodating up to 20 ports
• Multiband support based on customizations: 696-960, 1695-2700, 3300-4200 & 5150-5925 MHz
• Compact form factor for pole mount or integrated application
• Outstanding performance with optimal gain and
• Ideal for multi-carrier and MIMO deployment 
• Rugged build for long life and reliability

“As the industry gears up for 5G deployments, Sinclair is excited to announce the launch of the SSOP family of small cell antennas. These antennas are highly customizable to support various frequency bands, port counts, down tilts, and radiation patterns to enable reliable wireless coverage. They also feature high-quality compact UV-resistant fiberglass radomes to help operators overcome cell densification and network reliability challenges,” says Wee Er, Executive General Manager at Sinclair Technologies. 

Small Cell Antenna SSOP1 Series is available for immediate order.

For more information, please visit www.sinctech.com.

Sinclair Technologies, a division of Norsat International Inc., is a leading designer and manufacturer of antenna and RF signal conditioning products, systems, and coverage solutions. Sinclair products are used extensively in public safety and private industry communication networks, such as emergency services, transportation, natural resources, and utilities. We have over 70 years of industry-leading expertise in all aspects of antenna and RF signal conditioning design and manufacturing. 

-30-

Contact Information:

Anna Pluciennik

Marketing & Communications Manager

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Sinclair Technologies Announces 14-Port Small Cell Antenna of the New SSOP1 Series

CCT’s Award-Winning Stable Air® Equipment and Foaming Agent provides diverse installation solutions.

BRADENTON, Fla. – November 1, 2022 – (Newswire.com)

Cellular Concrete Technologies LLC (CCT), the makers of award-winning Stable Air® cellular concrete equipment and foaming agent, is introducing STABLE Road ™ for road base construction in the United States. The road base utilizes CCT’s CCM 1000 mobile batch plant, Stable Air® foaming agent and aerator equipment. This equipment and materials are now available to road builders nationwide to lease or subcontract services.

Cellular Concrete STABLE Road™ base is a proven technology that can cost 50% less than conventional sand and gravel base. It also reduces pollution by eliminating sand and gravel. STABLE Road™ base is self-leveling and easily placed without heavy equipment and is 100% self-compacted and can be poured in lifts up to 3 feet when conventional sand and gravel must be compacted in 12″ lifts and be inspected at each lift. The use of cellular concrete as a base for sidewalks and roads creates an extremely rigid foundation, thus prolonging the life span of the pavement and reducing maintenance costs. The use of cellular concrete also reduces any damage that dumping and compacting of loose materials may violate and weaken the soil subgrade. This material is easy to use as cellular concrete has a liquid consistency and completely fills all voids in even the roughest excavation. Monolithic non-porous cellular concrete can be cast and aligned exactly to the required thickness. STABLE Road™ base typically requires three to four times less thickness than the loose materials of sand and gravel, and therefore, reduces equally the depth of the pit. STABLE Road™ base also provides protection from the subgrade softening in precipitation. 

In addition to the road base project in Dhaka Bangladesh, CCT’s Stable Air® cellular concrete is being used in many diverse construction projects in the USA and Canada as well. CCT’s Stable Air® cellular concrete was used in the reconstruction of a dam in Southwest Florida for a major utility company, a hydroelectric dam in Ohio as well as New York City cruise terminal piers 88 and 90.  

This new method and technology will save tens of millions of dollars in cost and thousands of labor hours, as well as reduce the emission of greenhouse gasses for years to come around the globe

Contact Information:

Paul Falco

[email protected]

949-573-0509

Press Release Service
by
Newswire.com

Original Source:

Cellular Concrete Technologies Introducing STABLE Road™

Dimplex diversifies its roster of linear electric fireplaces with a new slim design

Dimplex Multi-Fire Slim Built-in Linear Electric Fireplace
…

NEW YORK & PITTSBURGH – November 1, 2022 – (Newswire.com)

• Platform is powered by Cedar’s innovative Payer Intelligence Layer, and is a key component of Highmark Health’s Living Health care model 
• Delivers real-time access to medical bills, benefits coverage verification, deductible status, health savings account balances and more

During a single healthcare encounter, a typical consumer may have multiple, disconnected interactions with their provider and payer about the financial aspects of their visit. For example, consumers looking to pay a bill, check their deductible progress or verify their health benefit account balance might have to utilize multiple communications methods, such as phone calls, apps or provider- and insurer-affiliated web portals. 

This lack of alignment leads to frustration and confusion for consumers, resulting in missed payments, overspending, administrative waste and money left on the table for consumers, who may be unaware of their available spending account funds. Not only do U.S. consumers spend 12 million hours a week on the phone with health insurers, but more than one-third of consumers have been sent to debt collections because of a billing issue between their healthcare provider and health insurer.

To address the systemic challenges consumers face when paying for healthcare, Cedar, an enterprise healthcare engagement platform that improves the end-to-end consumer financial journey, has developed the Payer Intelligence Layer. With the Payer Intelligence Layer, Cedar can now integrate data from health insurers and healthcare providers to help create a single source of information for consumers managing medical bills. A game-changer for the healthcare industry, Pittsburgh-based Highmark Inc. and Allegheny Health Network (AHN) will be the first to launch the new technology for services provided to Highmark Inc. members at AHN wholly owned providers and facilities.

“For too long, payer and provider misalignment has led to a poor experience and lack of clarity for consumers managing healthcare bills — this is a system problem, requiring a system solution,” said Seth Cohen, president of Cedar. “When each party plays a separate role, neither can fix the experience alone. But by bringing both sides together, we can create the best possible experience, reducing billing friction for consumers while delivering more efficient operations for payers and providers.” 

Initially available with Cedar Pay, the company’s billing and payment solution, the Payer Intelligence Layer enables consumers to access insurance explanation of benefits, real-time deductible status and health benefit accounts in the same place where they view and resolve medical bills — using a single, intuitive interface. Unlike other patient billing solutions, Cedar ensures consumers have the most up-to-date benefits information at their fingertips by directly integrating with health insurers as well as banks, which are responsible for administering health savings accounts, flexible spending accounts and health reimbursement accounts.

“Healthcare billing can be fragmented, cumbersome and overwhelming to navigate,” said Neil Kulkarni, vice president, Customer and Clinician Experience Solutions at Highmark Health. “Consumers want clear, easy-to-understand bills for their care and a simple way to pay — with their spending account information available across all channels. As part of Highmark Health’s Living Health model designed to deliver a blended and seamless health care experience, our collaboration with Cedar will help us to meet those customer expectations,” he said.

“The financial experience in healthcare is a real pain point for most consumers, and for most care providers. The issues associated with healthcare billing can only be resolved if all major players come together and collaborate for the benefit of consumers,” said James Rohrbaugh, chief financial officer and treasurer at Allegheny Health Network. “Our work with Cedar will be important in driving real progress in this area, helping our patients and members with an intuitive experience that fosters a sense of control and understanding about their financial responsibility.”

AHN and Highmark are collaborating with Cedar in distinct but integrated ways. Patients who visit AHN providers and facilities will experience the new and enhanced billing, statement and call center process, and simplified access to flexible payment options, all driven by the Cedar Pay platform. For AHN patients who are also enrolled as Highmark members, the enhancements multiply. Beginning at the end of October, the nearly 300,000 members visiting AHN providers will now have the added benefit of having their insurance information incorporated directly into a single billing statement. Members will see how their benefits have been applied, available health spending account funds and their progress towards their deductible and out-of-pocket limits — both when paying AHN bills online, and on the mailed paper statements. 

“We’re excited to be launching with healthcare industry leaders Highmark Health and Allegheny Health Network to solve this persistent problem,” added Cohen, Cedar’s president. “But this is only the beginning: Cedar is continuing to explore more ways of leveraging payer data and new integrations to enrich the end-to-end healthcare experience for today’s consumers.” 

About Cedar

Cedar is committed to improving the healthcare financial experience for all. With an innovative platform that connects providers and payers, Cedar empowers healthcare consumers with an optimized journey — all powered by data science and interactive design. For Cedar clients, this leads to increased payments, more efficient operations and greater consumer loyalty. To learn more about why leading U.S. healthcare organizations trust Cedar to manage the end-to-end consumer experience from pre-registration to post-visit billing, visit www.cedar.com and join us on LinkedIn, Twitter, Facebook and YouTube.

About Highmark Health

Highmark Health, a Pittsburgh, Pennsylvania-based enterprise that employs more than 37,000 people who serve millions of Americans across the country, is the parent company of Highmark Inc., Allegheny Health Network, enGen, Helion, and Lumevity. Highmark Inc. and its subsidiaries and affiliates provide health insurance to more than six million members in Pennsylvania, West Virginia, Delaware, and New York, as well as dental insurance, and related health products through a national network of diversified businesses. Allegheny Health Network is an integrated delivery network in western Pennsylvania comprised of 14 hospitals, more than 2,600 affiliated physicians, ambulatory surgery centers, an employed physician organization, home and community-based health services, a research institute, a group purchasing organization, and health and wellness pavilions. enGen is focused on meeting the information technology platform and other business needs of the Highmark Health enterprise as well as unaffiliated health insurance plans by providing proven business processes, expert knowledge, and integrated cloud-based platforms. Helion works with payers to cultivate high-performing networks while empowering providers to operate at their best. Lumevity helps companies transform in ways that drive direct financial benefits while improving quality and increasing employee engagement. To learn more, visit www.highmarkhealth.org.

About Allegheny Health Network

Allegheny Health Network (AHN.org), a Highmark Health company, is an integrated health care delivery system serving the greater Western Pennsylvania region. The network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home- and community-based health services, a research institute, and a group purchasing organization. AHN provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, cardiovascular disease, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff, and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Contact Information:

Rachel Borowski

Highmark Health

[email protected]

Bill Toland

Allegheny Health Network

[email protected]

Jenny Fiegoli

Cedar

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Cedar’s Integrated Payer-Provider Patient Billing Platform Introduced to Highmark Inc. and Allegheny Health Network Customers

Innovation sets Dimplex apart!

Dimplex Ignitexl Bold Built-in Linear Electric Fireplace
VANCOUVER, Wash. – …

Mr. Trippe plans to use the skills, judgment and knowledge he developed as a senior government and corporate lawyer — and as a national and regional firm litigation partner — in the resolution of complex and high-val…

Headwall’s Founder and Managing Partner Peter J. Scott to Present ‘M&A — The Optimal Path to Service Center Growth’

DELRAY BEACH, Fla. – November 1, 2022 – (Newswire.com)

 Headwall Partners LLC (“Headwall”), an independent corporate finance and strategic advisory firm focused principally on the steel & metals industry today announced that its founder and Managing Partner Peter J. Scott will present today as a part of the Metals Service Center Institute (“MSCI”) Webinar Series.

Scott commented, “I am delighted to have been asked to share my perspective on mergers and acquisitions in the metals service center sector. The MSCI’s Webinar Series is a forum for metals industry executives and experts to present to the MSCI’s membership, and I am excited to present my thoughts on mergers & acquisitions to such an important group.” 

About the Metals Service Center Institute:    

More than 100 years strong, the Metals Service Center Institute (“MSCI”) is the broadest-based, not-for-profit association serving the industrial metals industry. The MSCI provides vision and voice to the metals industry, along with the tools and perspective necessary for a more successful business. The MSCI offers its service centers, producing mills, and affiliate members an impressive array of high-level programs and services. Its goal is to meet its members’ needs for knowledge and thought leadership, provide data and education for operational efficiency, promote industry advocacy, and create a marketplace for efficient transactions, debate, discussion, and learning.

About Headwall Partners LLC:    

Headwall Partners LLC is a corporate finance and strategic advisory firm focused on the steel, metals, and materials industries. Led by veteran investment banker Peter J. Scott, Headwall provides strategic advice on mergers, acquisitions, debt and equity private placements, restructurings, valuations, and other financial services. Clients rely on Headwall Partners for its in-depth metals industry knowledge, candid advice, and intellectual rigor. Headwall Partners is based in Delray Beach, Florida, and serves clients globally. For more information, please visit www.headwallpartners.com.

Transactions in securities are executed by a registered broker dealer.

Contact Information:

Peter J Scott

Managing Partner

[email protected]

+1 855-432-3925

Press Release Service
by
Newswire.com

Original Source:

Headwall Partners to Present as a Part of the Metals Service Center Institute’s Webinar Series

Newest Hire Strengthens Infillion’s Leadership Team as Company Continues to Rapidly Grow Its Business

LOS ANGELES – November 1, 2022 – (Newswire.com)

Infillion, an advertising platform built for the connected future, today announced the appointment of Margaret Chu as chief financial officer. This announcement comes after her work as an executive advisor at Infillion. As an experienced business leader across media, advertising and technology, Margaret will work closely with Infillion’s management team to advance the company’s growth strategy as it continues to expand its presence as a leader in media technology.

“Infillion is growing rapidly, and having a savvy business partner like Margaret, who knows how to drive organic and inorganic growth, will help us move into the next phase of success,” said Rob Emrich, Founder and Executive Chair, Infillion. “Margaret has a proven track record of building successful companies and has been instrumental in corporate development activity in the media industry for a number of years. We are looking forward to putting her vast expertise to work at Infillion.”

Based in New York City, Margaret brings more than 20 years of relevant experience. Prior to joining Infillion’s executive leadership team, she served as chief financial officer at Vox Media where she delivered unprecedented financial results. Margaret has held previous executive roles at Horizon Media and RSE Ventures where she led legal, corporate strategy, investments, mergers and acquisitions and financial operations. Margaret has also served as board director or observer at Momofuku, Milk Bar, Legendary Entertainment and TransDigm Group. She is a proud alumna of Dartmouth College and Harvard Business School, where she earned her MBA.

“Infillion is an outstanding company in a sea of media technology solutions. Infillion’s impressive performance to-date and strong balance sheet positions the company to be nimble in how we choose to grow,” said Margaret Chu, CFO, Infillion. “I look forward to working with Infillion’s management team to develop dynamic tech that humanizes digital experiences for consumers and delivers great results for brands and agencies.”

Margaret officially joined the team in September, on the heels of welcoming Christa Carone as President of Infillion Media and Laurel Rossi as Chief Marketing Officer, well-known industry leaders in the media and advertising industries. 

For more information on Infillion and its people, visit https://infillion.com/. 

About Infillion

Infillion is an advertising platform built for the connected future and Web3. Working across more than 1,200 brands, such as Amazon, Microsoft, Bank of America and T-Mobile and all major agencies and holding companies, Infillion provides full-service media solutions that respect and prioritize consumers’ time, attention and privacy. Infillion’s CTV advertising solutions offer unparalleled scale with premium inventory, unconstrained by walled gardens. The company is devoted to innovating advertising by improving the user experience and providing advertisers and publishers with engaging, interactive ad formats that captivate consumers while respecting their time and providing an opportunity to opt-in. Infillion launched in February as the result of Gimbal’s acquisition of adtech CTV pioneer true[X] from Disney in late 2020. Both companies have been driving customer engagement with proprietary technology and first-party data since the beginning of marketing’s transformation to digital.

Contact Information:

Alyssa Kehoe

DiGennaro Communications

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Infillion Appoints Margaret Chu as CFO

As published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm’s sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation.

LAS VEGAS – November 1, 2022 – (Newswire.com)

Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation. Finding Cannabis compounds with anti-inflammatory properties may be useful in decreasing inflammation associated with a wide range of serious human disorders, and these Cannabis compounds potentially have more favorable side effect profiles than NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), which currently lead the anti-inflammatory market based on sales. Largely because of the increasing prevalence of chronic and auto-immune inflammatory disorders, the market for anti-inflammatory therapies is expected to grow to $191.42 billion by 2027.

“We believe that this is the first demonstration of the anti-inflammatory potential of some very potent minor cannabinoids and terpenes derived from Cannabis,” said Dr. Andrea Small-Howard, President, Chief Science Officer, and Director of Gb Sciences. “The identification of cell type-specific immune modulating effects by different individual cannabinoids and terpenes was an important first step in designing our novel anti-inflammatory therapies. The results from our second study on the anti-inflammatory effects of proprietary mixtures of these ingredients will be published subsequently with our collaborators at Michigan State University and Chaminade University.”

Gb Sciences selected the specific Cannabis constituents for this study based on their prior activity within chemovar studies. To determine whether these cannabinoids and terpenes could reduce inflammation, Gb Sciences’ colleagues at Michigan State University tested the individual Cannabis constituents over a wide range of concentrations in human, primary immune cells in a co-culture system that mimics the complex interactions that regulate the human immune system. Three immune cell types were chosen as representatives within these native human immune cell mixtures based on their important roles in modulating the inflammatory cascade.

This study demonstrated that delta-9 tetrahydrocannabinol (THC) had the greatest effect on reducing inflammatory biomarkers and processes in all three immune cell types. Following THC, the greatest immune activity modulation was measured by cannabidivarin (CBDV), cannabigerol (CBG), cannabichromene (CBC), cannabinol (CBN), and lastly, cannabidiol (CBD) in decreasing order based on the number of statistically significant changes measured in inflammatory bioassays relative to the control. Some of these minor cannabinoids and the terpenes tested had very ‘selective’ anti-inflammatory effects, which targeted a single cell type and/or caused a change in only a single inflammatory bioassay.

This study entitled “Evaluation of the anti-inflammatory effects of selected cannabinoids and terpenes from Cannabis Sativa employing human primary leukocytes” was co-authored by Gb Sciences’ own President and Chief Science Officer, Andrea Small-Howard, and her collaborators Lance K. Blevins, Anthony P. Bach, Robert B. Crawford, Jiajun Zhou, Joseph E. Henriquez, Michael D. Rizzo, Sera Sermet, D.M. Isha Olive Khan, and Norbert Kaminski from Michigan State University (East Lansing, Michigan, USA) and Helen Turner from Chaminade University of Honolulu (Honolulu, Hawai’i, USA). The second part of this study measured the effects of proprietary mixtures of cannabinoids and terpenes on inflammation within this human, primary immune cell model, and this second study will be published next in collaboration with our colleagues at Michigan State University and Chaminade University.

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The ‘plant-inspired’ active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences’ intellectual property portfolio contains six issued U.S. and three issued foreign patents, as well as 17 U.S. and 51 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences’ lead program for Parkinson’s disease is being prepared for a first-in-human clinical trial. Gb Sciences’ formulations for chronic pain, anxiety, and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada. The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome related to COVID-19, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences’ productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company’s control. It is possible that the Company’s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company’s business and financial and other results, are contained in the Company’s filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:

Madeleine Moench

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients